Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06091202 · ClinicalTrials.gov registry record · Phase 3

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

A Phase 3 study of Chronic Pain, sponsored by Oregon Health and Science University.

Recruiting
Registry status
Phase 3
Development phase
608
Enrollment target
4
Study locations

NCT06091202: Recruiting Phase 3 study of Chronic Pain, sponsored by Oregon Health and Science University.

NCT06091202 is a Phase 3 study of Chronic Pain that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 608 participants, below the 770-participant average among 301 other Chronic Pain trials with a reported enrollment target (21% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06091202, a Phase 3 study of Chronic Pain, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
Phase 3
Development phase
608 participants
Enrollment target
4
Study locations

Study Summary

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanced usual care to improve pain interference over 12 months of follow-up, and (2) oversample women and rural veterans of minoritized race/ethnicity to test heterogeneity of treatment effects across birth sex and race/ethnicity.

Primary Outcome

Pain Interference subscale from the Brief Pain Inventory. Scores are reported on a range of 0 - 10, with higher scores indicating more impairment due to pain.

Conditions Studied

Interventions

  • BEHAVIORAL CORPs Intervention
  • BEHAVIORAL Minimally Enhanced Usual Care (MEUC)

Study Locations (4)

Minnesota

  • VA Minneapolis Health Care System - Minneapolis

Oregon

  • VA Portland Health Care System - Portland

Tennessee

  • VA Tennessee Valley Health Care System - Nashville

Texas

  • VA North Texas Health Care System - Dallas

Trial Details

FieldValue
Enrollment Target 608 participants
Start Date 2024-07-11
Est. Completion 2027-06-01
Phase Phase 3

What NCT06091202 shows while recruiting

NCT06091202 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, below the 770-participant average among 301 other Chronic Pain trials with a reported enrollment target (21% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which CORPs Intervention is the first listed.

NCT06091202 reports a single indexed study location in Minnesota, Oregon, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06091202 about?

NCT06091202 is a clinical study titled "Tele-Collaborative Outreach to Rural Patients With Chronic Pain". This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims of the study are: (1) compare the effectiveness of tele-collaborative pain care vs. minimally enhanc...

What is the current status of trial NCT06091202?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 608 participants. The study started on 2024-07-11. Estimated completion is 2027-06-01.

What conditions does trial NCT06091202 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06091202?

The interventions under investigation include: CORPs Intervention (BEHAVIORAL), Minimally Enhanced Usual Care (MEUC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06091202?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06091202 being conducted?

This trial has 4 study locations across Minnesota, Oregon, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06091202's enrollment target sits among peer trials

608 16th of 301 higher than 286 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02064673 · 608 participants · Phase 3

    Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

  • NCT06098144 · 608 participants · Phase 4

    Smoking Cessation Program in the Construction Sector

  • NCT00823654 · 609 participants

    Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

  • NCT03536312 · 610 participants · NA

    Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06091202, the US trial registry maintained by the National Library of Medicine. NCT06091202 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.